返回
Clover Biopharmaceuticals, Ltd.（02197.HK）價格
02197.HK 股價走勢圖
CLOVER BIO-B (02197.HK)
Clover Biopharmaceuticals, Ltd.
HK$2.59
-1.14%
$-0.03
休市： Jan 16, 16:00:00 HKT
關鍵數據
前收市價
$2.62
開盤價
$2.62
當日範圍
$2.5 - $2.65
52週區間
$0.185 - $3.18
交易量
4.9M
平均成交量
10.9M
每股盈餘 (TTM)
-0.80
股息收益率
--
市值
$3.3B
什麼是 CLOVER BIO-B？
Clover Biopharmaceuticals Ltd. engages in the research and development of biopharmaceutical products. The company is headquartered in Shanghai, Shanghai and currently employs 243 full-time employees. The company went IPO on 2021-11-05. The Company’s products and candidates include Respiratory Syncytial Virus (RSV) Vaccine (SCB-1019), seasonal quadrivalent influenza vaccine AdimFlu-S, SCB-219M, COVID-19 Vaccine and others. The firm leverages the Trimer-Tag technology platform to conduct research and development (R&D) for innovative vaccines that can fulfill unmet need, with a focus on building a respiratory vaccine franchise and establishing a presence in the pediatric vaccine market. The Trimer-Tag is a product development platform for the creation of protein-based vaccines based on naturally trimerization-dependent targets. The firm conducts its business in the domestic and overseas markets.